BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19411600)

  • 1. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.
    Norman PJ; Abi-Rached L; Gendzekhadze K; Hammond JA; Moesta AK; Sharma D; Graef T; McQueen KL; Guethlein LA; Carrington CV; Chandanayingyong D; Chang YH; Crespí C; Saruhan-Direskeneli G; Hameed K; Kamkamidze G; Koram KA; Layrisse Z; Matamoros N; Milà J; Park MH; Pitchappan RM; Ramdath DD; Shiau MY; Stephens HA; Struik S; Tyan D; Verity DH; Vaughan RW; Davis RW; Fraser PA; Riley EM; Ronaghi M; Parham P
    Genome Res; 2009 May; 19(5):757-69. PubMed ID: 19411600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors.
    Alicata C; Ashouri E; Nemat-Gorgani N; Guethlein LA; Marin WM; Tao S; Moretta L; Hollenbach JA; Trowsdale J; Traherne JA; Ghaderi A; Parham P; Norman PJ
    Front Immunol; 2020; 11():556. PubMed ID: 32300348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.
    Guinan KJ; Cunningham RT; Meenagh A; Gonzalez A; Dring MM; McGuinness BW; Middleton D; Gardiner CM
    Genes Immun; 2010 Sep; 11(6):467-78. PubMed ID: 20200544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.
    Crum KA; Logue SE; Curran MD; Middleton D
    Tissue Antigens; 2000 Oct; 56(4):313-26. PubMed ID: 11098931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC.
    Wroblewski EE; Parham P; Guethlein LA
    Front Immunol; 2019; 10():177. PubMed ID: 30837985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.
    Shilling HG; Guethlein LA; Cheng NW; Gardiner CM; Rodriguez R; Tyan D; Parham P
    J Immunol; 2002 Mar; 168(5):2307-15. PubMed ID: 11859120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.
    Abi-Rached L; Moesta AK; Rajalingam R; Guethlein LA; Parham P
    PLoS Genet; 2010 Nov; 6(11):e1001192. PubMed ID: 21079681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluctuating and Geographically Specific Selection Characterize Rapid Evolution of the Human
    Augusto DG; Norman PJ; Dandekar R; Hollenbach JA
    Front Immunol; 2019; 10():989. PubMed ID: 31156615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
    Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
    Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population.
    Belle I; Hou L; Chen M; Steiner NK; Ng J; Hurley CK
    Tissue Antigens; 2008 May; 71(5):434-9. PubMed ID: 18331531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic and evolutionary balances in human NK cell receptor diversity.
    Parham P
    Semin Immunol; 2008 Dec; 20(6):311-6. PubMed ID: 19036608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.
    Parham P; Norman PJ; Abi-Rached L; Guethlein LA
    Philos Trans R Soc Lond B Biol Sci; 2012 Mar; 367(1590):800-11. PubMed ID: 22312047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
    Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
    PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing technology a new tool for killer cell immunoglobulin-like receptor allele typing in hematopoietic stem cell transplantation.
    Maniangou B; Retière C; Gagne K
    Transfus Clin Biol; 2018 Feb; 25(1):87-89. PubMed ID: 29032017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop.
    Misra MK; Augusto DG; Martin GM; Nemat-Gorgani N; Sauter J; Hofmann JA; Traherne JA; González-Quezada B; Gorodezky C; Bultitude WP; Marin W; Vierra-Green C; Anderson KM; Balas A; Caro-Oleas JL; Cisneros E; Colucci F; Dandekar R; Elfishawi SM; Fernández-Viña MA; Fouda M; González-Fernández R; Große A; Herrero-Mata MJ; Hollenbach SQ; Marsh SGE; Mentzer A; Middleton D; Moffett A; Moreno-Hidalgo MA; Mossallam GI; Nakimuli A; Oksenberg JR; Oppenheimer SJ; Parham P; Petzl-Erler ML; Planelles D; Sánchez-García F; Sánchez-Gordo F; Schmidt AH; Trowsdale J; Vargas LB; Vicario JL; Vilches C; Norman PJ; Hollenbach JA
    Hum Immunol; 2018 Dec; 79(12):825-833. PubMed ID: 30321631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.
    Norman PJ; Abi-Rached L; Gendzekhadze K; Korbel D; Gleimer M; Rowley D; Bruno D; Carrington CV; Chandanayingyong D; Chang YH; Crespí C; Saruhan-Direskeneli G; Fraser PA; Hameed K; Kamkamidze G; Koram KA; Layrisse Z; Matamoros N; Milà J; Park MH; Pitchappan RM; Ramdath DD; Shiau MY; Stephens HA; Struik S; Verity DH; Vaughan RW; Tyan D; Davis RW; Riley EM; Ronaghi M; Parham P
    Nat Genet; 2007 Sep; 39(9):1092-9. PubMed ID: 17694054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2
    Nemat-Gorgani N; Hilton HG; Henn BM; Lin M; Gignoux CR; Myrick JW; Werely CJ; Granka JM; Möller M; Hoal EG; Yawata M; Yawata N; Boelen L; Asquith B; Parham P; Norman PJ
    J Immunol; 2018 Apr; 200(8):2640-2655. PubMed ID: 29549179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians.
    Deng Z; Zhen J; Harrison GF; Zhang G; Chen R; Sun G; Yu Q; Nemat-Gorgani N; Guethlein LA; He L; Tang M; Gao X; Cai S; Palmer WH; Shortt JA; Gignoux CR; Carrington M; Zou H; Parham P; Hong W; Norman PJ
    Mol Biol Evol; 2021 May; 38(6):2582-2596. PubMed ID: 33616658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
    Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
    J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic diversity of KIR3DL1/3DS1 in a southern Chinese population.
    Deng Z; Zhen J; Zhu B; Zhang G; Yu Q; Wang D; Xu Y; He L; Lu L
    Hum Immunol; 2015 Sep; 76(9):663-6. PubMed ID: 26416088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.